Association between exposure to air pollution and blood lipids in the general population of Spain.

HDL air pollution cholesterol lipids lipoprotein triglyceride

Journal

European journal of clinical investigation
ISSN: 1365-2362
Titre abrégé: Eur J Clin Invest
Pays: England
ID NLM: 0245331

Informations de publication

Date de publication:
05 Oct 2023
Historique:
revised: 13 09 2023
received: 27 07 2023
accepted: 23 09 2023
medline: 5 10 2023
pubmed: 5 10 2023
entrez: 5 10 2023
Statut: aheadofprint

Résumé

We aimed to assess the associations of exposure to air pollutants and standard and advanced lipoprotein measures, in a nationwide sample representative of the adult population of Spain. We included 4647 adults (>18 years), participants in the national, cross-sectional, population-based di@bet.es study, conducted in 2008-2010. Standard lipid measurements were analysed on an Architect C8000 Analyzer (Abbott Laboratories SA). Lipoprotein analysis was made by an advanced In multivariate linear regression models, each IQR increase in PM Our study shows an association between the exposure to air pollutants and blood lipids in the general population of Spain, suggesting a link to atherosclerosis.

Sections du résumé

BACKGROUND AND AIMS OBJECTIVE
We aimed to assess the associations of exposure to air pollutants and standard and advanced lipoprotein measures, in a nationwide sample representative of the adult population of Spain.
METHODS METHODS
We included 4647 adults (>18 years), participants in the national, cross-sectional, population-based di@bet.es study, conducted in 2008-2010. Standard lipid measurements were analysed on an Architect C8000 Analyzer (Abbott Laboratories SA). Lipoprotein analysis was made by an advanced
RESULTS RESULTS
In multivariate linear regression models, each IQR increase in PM
CONCLUSIONS CONCLUSIONS
Our study shows an association between the exposure to air pollutants and blood lipids in the general population of Spain, suggesting a link to atherosclerosis.

Identifiants

pubmed: 37795744
doi: 10.1111/eci.14101
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

e14101

Subventions

Organisme : Consejería de Salud y Bienestar Social, Junta de Andalucía
ID : RC-0006-2016
Organisme : Instituto de Salud Carlos III
ID : CM21/00214
Organisme : Instituto de Salud Carlos III
ID : INT21/00037
Organisme : Instituto de Salud Carlos III
ID : PI17/02136
Organisme : Instituto de Salud Carlos III
ID : PI20/01322

Informations de copyright

© 2023 The Authors. European Journal of Clinical Investigation published by John Wiley & Sons Ltd on behalf of Stichting European Society for Clinical Investigation Journal Foundation.

Références

WHO. Ambient (Outdoor) Air Pollution Key Facts. World Health Organization; 2022. Accessed October 3, 2023. https://www.who.int/news-room/fact-sheets/detail/ambient-(outdoor)-air-quality-and-health
Brook RD, Rajagopalan S, Pope CA 3rd, et al. Particulate matter air pollution and cardiovascular disease: an update to the scientific statement from the American Heart Association. Circulation. 2010;121:2331-2378.
Cosselman KE, Navas-Acien A, Kaufman JD. Environmental factors in cardiovascular disease. Nat Rev Cardiol. 2015;11:627-642.
Rajagopalan S, Al-Kindi SG, Brook RD. Air pollution and cardiovascular disease: JACC state-of-the-art review. J Am Coll Cardiol. 2018;17:2054-2070.
Al-Kindi SG, Brook RD, Biswal S, Rajagopalan S. Environmental determinants of cardiovascular disease: lessons learned from air pollution. Nat Rev Cardiol. 2020;10:656-672.
Sørensen M, Hjortebjerg D, Eriksen KT, et al. Exposure to long-term air pollution and road traffic noise in relation to cholesterol: a cross-sectional study. Environ Int. 2015;85:238-243.
Shanley RP, Hayes RB, Cromar KR, Ito K, Gordon T, Ahn J. Particulate air pollution and clinical cardiovascular disease risk factors. Epidemiology. 2016;27(2):291-298.
Yitshak-Sade M, Kloog I, Liberty IF, Schwartz J, Novack V. The association between air pollution exposure and glucose and lipids levels. J Clin Endocrinol Metab. 2016;101(6):2460-2467.
Bell G, Mora S, Greenland P, Tsai M, Gill E, Kaufman JD. Association of air pollution exposures with high-density lipoprotein cholesterol and particle number: the multi-ethnic study of atherosclerosis. Arterioscler Thromb Vasc Biol. 2017;37(5):976-982.
Yang BY, Bloom MS, Markevych I, et al. Exposure to ambient air pollution and blood lipids in adults: the 33 Communities Chinese Health Study. Environ Int. 2018;119:485-492.
Gaio V, Roquette R, Dias CM, Nunes B. Ambient air pollution and lipid profile: systematic review and meta-analysis. Environ Pollut. 2019;254:113036.
Kim JS, Chen Z, Alderete TL, et al. Associations of air pollution, obesity and cardiometabolic health in young adults: the meta-AIR study. Environ Int. 2019;133:105180.
McGuinn LA, Schneider A, McGarrah RW, et al. Association of long-term PM2.5 exposure with traditional and novel lipid measures related to cardiovascular disease risk. Environ Int. 2019;122:193-200.
Wu XM, Broadwin R, Basu R, et al. Associations between fine particulate matter and changes in lipids/lipoproteins among midlife women. Sci Total Environ. 2019;654:1179-1186.
Gui ZH, Yang BY, Zou ZY, et al. Exposure to ambient air pollution and blood lipids in children and adolescents: a national population-based study in China. Environ Pollut. 2020;266:115422.
Mao S, Li S, Wang C, et al. Is long-term PM1 exposure associated with blood lipids and dyslipidemias in a Chinese rural population? Environ Int. 2020;138:105637.
Mao S, Chen G, Liu F, et al. Long-term effects of ambient air pollutants to blood lipids and dyslipidemias in a Chinese rural population. Environ Pollut. 2020;256:113403.
Shin WY, Kim JH, Lee G, et al. Exposure to ambient fine particulate matter is associated with changes in fasting glucose and lipid profiles: a nationwide cohort study. BMC Public Health. 2020;20:430.
Kim HJ, Kwon H, Yun JM, Cho B, Park JH. Interaction between visceral adiposity and ambient air pollution on LDL cholesterol level in Korean adults. Int J Obes (Lond). 2021;45:547-554.
Li J, Yao Y, Xie W, et al. Association of long-term exposure to PM2.5 with blood lipids in the Chinese population: findings from a longitudinal quasi-experiment. Environ Int. 2021;151:106454.
Wang L, Chen G, Pan Y, et al. Association of long-term exposure to ambient air pollutants with blood lipids in Chinese adults: the China multi-ethnic cohort study. Environ Res. 2021;1977:111174.
Zhang K, Wang H, He W, et al. The association between ambient air pollution and blood lipids: a longitudinal study in Shijiazhuang, China. Sci Total Environ. 2021;752:141648.
Zhang W, Liu J, Hu D, et al. Joint effect of multiple air pollutants on lipid profiles in obese and normal-weight young adults: the key role of ozone. Environ Pollut. 2022;292:118247.
Kim KN, Ha B, Seog W, Hwang IU. Long-term exposure to air pollution and the blood lipid levels of healthy young men. Environ Int. 2022;161:107119.
Pichler G, Amigo N, Tellez-Plaza M, et al. LDL particle size and composition and incident cardiovascular disease in a South-European population: the Hortega-Liposcale follow-up study. Int J Cardiol. 2018;264:172-178.
Würtz P, Raiko JR, Magnussen CG, et al. High-throughput quantification of circulating metabolites improves prediction of subclinical atherosclerosis. Eur Heart J. 2012;33:2307-2316.
Mora S, Buring JE, Ridker PM. Discordance of low-density lipoprotein (LDL) cholesterol with alternative LDL-related measures and future coronary events. Circulation. 2014;129:553-561.
Tehrani DM, Zhao Y, Blaha MJ, et al. Discordance of low-density lipoprotein and high-density lipoprotein cholesterol particle versus cholesterol concentration for the prediction of cardiovascular disease in patients with metabolic syndrome and diabetes mellitus (from the multi-ethnic study of atherosclerosis [MESA]). Am J Cardiol. 2016;117:1921-1927.
Aday AW, Lawler PR, Cook NR, Ridker PM, Mora S, Pradhan AD. Lipoprotein particle profiles, standard lipids, and peripheral artery disease incidence. Circulation. 2018;138:2330-2341.
Soriguer F, Goday A, Bosch-Comas A, et al. Prevalence of diabetes mellitus and impaired glucose regulation in Spain: the Di@bet.es Study. Diabetologia. 2012;55:88-93.
World Medical Association. World Medical Association declaration of Helsinki: ethical principles for medical research involving human subjects. JAMA. 2013;310:2191-2194.
Schröder H, Fitó M, Estruch R, et al. A short screener is valid for assessing Mediterranean diet adherence among older Spanish men and women. J Nutr. 2011;141:1140-1145.
International Physical Activity Questionnaire. Accessed October 3, 2023. https://sites.google.com/view/ipaq
Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults. Executive summary of the third report of the National Cholesterol Education Program (NCEP) expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (adult treatment panel III). JAMA. 2001;285:2486-2497.
Mallol R, Amigó N, Rodríguez MA, et al. Liposcale: a novel advanced lipoprotein test based on 2D diffusion-ordered 1H NMR spectroscopy. J Lipid Res. 2015;56:737-746.
Menut L, Bessagnet B, Khvorostyanov D, et al. CHIMERE 2013: a model for regional atmospheric composition modelling. Geosci Model Dev. 2013;6:981-1028.
Vivanco MG, Palomino I, Vautard R, et al. Multi-year assessment of photochemical air quality simulation over Spain. Environ Model Softw. 2009;24:63-73.
Vivanco MG, Azula O, Palomino I, Martín F. Evaluating the impact of resolution on the predictions of an air quality model over Madrid area (Spain). In: Murgante B, Borruso G, Lapucci A, eds. Geocomputation, Sustainability and Environmental Plan Theory. Springer; 2011:145-162.
Martín F, Palomino I, Vivanco MG. Combination of measured and modelling data in air quality assessment in Spain. Int J Environ Pollut. 2012;49:36-44.
Spanish National Meteorological Agency. Accessed October 3, 2023. http://www.aemet.es
Directive 2008/50/EC of the European Parliament and of the Council of 21 May 2008 on ambient air quality and cleaner air for Europe. Accessed October 3, 2023. https://eur-lex.europa.eu/eli/dir/2008/50/2015-09-18
Mora S, Szklo M, Otvos JD, et al. LDL particle subclasses, LDL particle size, and carotid atherosclerosis in the multi-ethnic study of atherosclerosis (MESA). Atherosclerosis. 2007;192:211-217.
Mora S, Glynn RJ, Ridker PM. High-density lipoprotein cholesterol, size, particle number, and residual vascular risk after potent statin therapy. Circulation. 2013;128:1189-1197.
Mackey RH, Greenland P, Goff DC Jr, Lloyd-Jones D, Sibley CT, Mora S. High-density lipoprotein cholesterol and particle concentrations, carotid atherosclerosis, and coronary events: MESA (multi-ethnic study of atherosclerosis). J Am Coll Cardiol. 2012;60:508-516.
Gepner AD, Piper ME, Johnson HM, Fiore MC, Baker TB, Stein JH. Effects of smoking and smoking cessation on lipids and lipoproteins: outcomes from a randomized clinical trial. Am Heart J. 2011;161:145-151.
Mathew AV, Yu J, Guo Y, et al. Effect of ambient fine particulate matter air pollution and colder outdoor temperatures on high-density lipoprotein function. Am J Cardiol. 2018;122:565-570.
Li J, Zhou C, Xu H, et al. Ambient air pollution is associated with HDL (high-density lipoprotein) dysfunction in healthy adults. Arterioscler Thromb Vasc Biol. 2019;39:513-522.
Otvos JD, Mora S, Shalaurova I, Greenland P, Mackey RH, Goff DC Jr. Clinical implications of discordance between low-density lipoprotein cholesterol and particle number. J Clin Lipidol. 2011;5:105-113.
Weichenthal S, Hoppin JA, Reeves F. Obesity and the cardiovascular health effects of fine particulate air pollution. Obesity. 2014;22:1580-1589.
Chen T, Jia G, Wei Y, Li J. Beijing ambient particle exposure accelerates atherosclerosis in ApoE knockout mice. Toxicol Lett. 2013;223:146-153.
Li R, Navab M, Pakbin P, et al. Ambient ultrafine particles alter lipid metabolism and HDL anti-oxidant capacity in LDLR-null mice. J Lipid Res. 2013;54:1608-1615.
Li H, Chen R, Cai J, Cui X, Huang N, Kan H. Short-term exposure to fine particulate air pollution and genome-wide DNA methylation: a randomized, double-blind, crossover trial. Environ Int. 2018;120:130-136.

Auteurs

Sergio Valdés (S)

Department of Endocrinology and Nutrition, Hospital Regional Universitario de Málaga/Universidad de Málaga, Instituto de Investigación Biomedica de Málaga-IBIMA, Málaga, Spain.
Centro de Investigación Biomédica en Red de Diabetes y Enfermedades Metabólicas Asociadas (CIBERDEM), Instituto de Salud Carlos III, Madrid, Spain.

Viyey Doulatram-Gamgaram (V)

Department of Endocrinology and Nutrition, Hospital Regional Universitario de Málaga/Universidad de Málaga, Instituto de Investigación Biomedica de Málaga-IBIMA, Málaga, Spain.

Cristina Maldonado-Araque (C)

Department of Endocrinology and Nutrition, Hospital Regional Universitario de Málaga/Universidad de Málaga, Instituto de Investigación Biomedica de Málaga-IBIMA, Málaga, Spain.
Centro de Investigación Biomédica en Red de Diabetes y Enfermedades Metabólicas Asociadas (CIBERDEM), Instituto de Salud Carlos III, Madrid, Spain.

Eva García-Escobar (E)

Department of Endocrinology and Nutrition, Hospital Regional Universitario de Málaga/Universidad de Málaga, Instituto de Investigación Biomedica de Málaga-IBIMA, Málaga, Spain.
Centro de Investigación Biomédica en Red de Diabetes y Enfermedades Metabólicas Asociadas (CIBERDEM), Instituto de Salud Carlos III, Madrid, Spain.

Sara García-Serrano (S)

Department of Endocrinology and Nutrition, Hospital Regional Universitario de Málaga/Universidad de Málaga, Instituto de Investigación Biomedica de Málaga-IBIMA, Málaga, Spain.
Centro de Investigación Biomédica en Red de Diabetes y Enfermedades Metabólicas Asociadas (CIBERDEM), Instituto de Salud Carlos III, Madrid, Spain.

Wasima Oualla-Bachiri (W)

Department of Endocrinology and Nutrition, Hospital Regional Universitario de Málaga/Universidad de Málaga, Instituto de Investigación Biomedica de Málaga-IBIMA, Málaga, Spain.
Centro de Investigación Biomédica en Red de Diabetes y Enfermedades Metabólicas Asociadas (CIBERDEM), Instituto de Salud Carlos III, Madrid, Spain.

Marta García-Vivanco (M)

Centro de Investigaciones Energéticas, Medioambientales y Tecnológicas (CIEMAT) - División de Contaminación Atmosférica, Madrid, Spain.

Juan Luis Garrido (JL)

Centro de Investigaciones Energéticas, Medioambientales y Tecnológicas (CIEMAT) - División de Contaminación Atmosférica, Madrid, Spain.

Victoria Gil (V)

Centro de Investigaciones Energéticas, Medioambientales y Tecnológicas (CIEMAT) - División de Contaminación Atmosférica, Madrid, Spain.

Fernando Martín-Llorente (F)

Centro de Investigaciones Energéticas, Medioambientales y Tecnológicas (CIEMAT) - División de Contaminación Atmosférica, Madrid, Spain.

Alfonso Calle-Pascual (A)

Centro de Investigación Biomédica en Red de Diabetes y Enfermedades Metabólicas Asociadas (CIBERDEM), Instituto de Salud Carlos III, Madrid, Spain.
Department of Endocrinology and Nutrition and Instituto de Investigación Sanitaria University Hospital S. Carlos (IdISSC), Department Medicine II, Universidad Complutense (UCM), Madrid, Spain.

Luis Castaño (L)

Centro de Investigación Biomédica en Red de Diabetes y Enfermedades Metabólicas Asociadas (CIBERDEM), Instituto de Salud Carlos III, Madrid, Spain.
Hospital Universitario Cruces, BioCruces, UPV/EHU, Barakaldo, Spain.
Centro de Investigación Biomédica en Red de Enfermedades Raras (CIBERER), Instituto de Salud Carlos III, Madrid, Spain.

Elías Delgado (E)

Department of Endocrinology and Nutrition, Hospital Universitario Central de Asturias/University of Oviedo, Instituto de Investigación Sanitaria del Principado de Asturias (ISPA), Oviedo, Spain.

Edelmiro Menéndez (E)

Department of Endocrinology and Nutrition, Hospital Universitario Central de Asturias/University of Oviedo, Instituto de Investigación Sanitaria del Principado de Asturias (ISPA), Oviedo, Spain.

Josep Franch-Nadal (J)

Centro de Investigación Biomédica en Red de Diabetes y Enfermedades Metabólicas Asociadas (CIBERDEM), Instituto de Salud Carlos III, Madrid, Spain.
EAP Raval Sud, Institut Català de la Salut, Red GEDAPS, Primary Care, Unitat de Suport a la Recerca (IDIAP - Fundació Jordi Gol), Barcelona, Spain.

Sonia Gaztambide (S)

Centro de Investigación Biomédica en Red de Diabetes y Enfermedades Metabólicas Asociadas (CIBERDEM), Instituto de Salud Carlos III, Madrid, Spain.
Centro de Investigación Biomédica en Red de Enfermedades Raras (CIBERER), Instituto de Salud Carlos III, Madrid, Spain.
Department of Endocrinology and Nutrition, Hospital Universitario Cruces - BioCruces Bizkaia - UPV-EHU, Baracaldo, Barcelona, Spain.

Joan Girbés (J)

Diabetes Unit, Hospital Arnau de Vilanova, Valencia, Spain.

F Javier Chaves (FJ)

Centro de Investigación Biomédica en Red de Diabetes y Enfermedades Metabólicas Asociadas (CIBERDEM), Instituto de Salud Carlos III, Madrid, Spain.
Genomic Studies and Genetic Diagnosis Unit, Fundación de Investigación del Hospital Clínico de Valencia - INCLIVA, Valencia, Spain.

José L Galán-García (JL)

Department of Applied Mathematics, University of Málaga, Málaga, Spain.

Gabriel Aguilera-Venegas (G)

Department of Applied Mathematics, University of Málaga, Málaga, Spain.

Joan Carles Vallvé (JC)

Centro de Investigación Biomédica en Red de Diabetes y Enfermedades Metabólicas Asociadas (CIBERDEM), Instituto de Salud Carlos III, Madrid, Spain.
Research Unit on Lipids and Atherosclerosis, Sant Joan University Hospital, Rovira i Virgili University, IISPV, Reus, Spain.

Núria Amigó (N)

Centro de Investigación Biomédica en Red de Diabetes y Enfermedades Metabólicas Asociadas (CIBERDEM), Instituto de Salud Carlos III, Madrid, Spain.
Metabolomics Platform, Universitat Rovira i Virgili, IISRV, Reus, Spain.
Biosfer Teslab, Reus, Spain.

Montse Guardiola (M)

Centro de Investigación Biomédica en Red de Diabetes y Enfermedades Metabólicas Asociadas (CIBERDEM), Instituto de Salud Carlos III, Madrid, Spain.
Research Unit on Lipids and Atherosclerosis, Sant Joan University Hospital, Rovira i Virgili University, IISPV, Reus, Spain.

Josep Ribalta (J)

Centro de Investigación Biomédica en Red de Diabetes y Enfermedades Metabólicas Asociadas (CIBERDEM), Instituto de Salud Carlos III, Madrid, Spain.
Research Unit on Lipids and Atherosclerosis, Sant Joan University Hospital, Rovira i Virgili University, IISPV, Reus, Spain.

Gemma Rojo-Martínez (G)

Department of Endocrinology and Nutrition, Hospital Regional Universitario de Málaga/Universidad de Málaga, Instituto de Investigación Biomedica de Málaga-IBIMA, Málaga, Spain.
Centro de Investigación Biomédica en Red de Diabetes y Enfermedades Metabólicas Asociadas (CIBERDEM), Instituto de Salud Carlos III, Madrid, Spain.

Classifications MeSH